Zoetis Inc.
ZTSAPI behind this page
ZTS Q4 2025 request
Playground key active
/api/financials?ticker=ZTS&year=2025&quarter=4
Pick an endpoint and run the request.Income Statement
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Revenue | 2,387 | 2,317 | +3.0% |
Show Product Lines breakouts |
|||
| Animal health diagnostics | 111 | 100 | +11.0% |
| Anti-infectives | 284 | 281 | +1.1% |
| Cattle | 415 | 399 | +4.0% |
| Companion Animal | 1,601 | 1,570 | +2.0% |
| Companion Animal · International Segment | 599 | 562 | +6.6% |
| Companion Animal · United States Segment | 1,002 | 1,008 | -0.6% |
| Contract Manufacturing and Human Health Diagnostics [Member] | 30 | 21 | +42.9% |
| Dermatology [Member] | 429 | 421 | +1.9% |
| Dogs and Cats | -4,479 | -4,231 | -5.9% |
| Fish | 81 | 65 | +24.6% |
| Horses | 6,080 | 5,801 | +4.8% |
| Livestock | 756 | 726 | +4.1% |
| Livestock · International Segment | 522 | 477 | +9.4% |
| Livestock · United States Segment | 234 | 249 | -6.0% |
| Manufactured Product Other | 18 | 17 | +5.9% |
| Medicated feed additives | 12 | 51 | -76.5% |
| Other non-pharmaceuticals | 70 | 65 | +7.7% |
| Other pharmaceuticals | 188 | 180 | +4.4% |
| Pain & Sedation | 209 | 217 | -3.7% |
| Parasiticides | 542 | 519 | +4.4% |
| Poultry | 117 | 117 | 0.0% |
| Swine | 125 | 128 | -2.3% |
| Total Products and Services | 2,357 | 2,296 | +2.7% |
| Vaccines | 512 | 462 | +10.8% |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | 278 | 243 | +14.4% |
| International Segment · Operating Segments | 1,121 | 1,039 | +7.9% |
| United States Segment · Operating Segments | 1,236 | 1,257 | -1.7% |
Show Geography breakouts |
|||
| AU | 84 | 80 | +5.0% |
| BR | 112 | 113 | -0.9% |
| CA | 80 | 75 | +6.7% |
| CL | 40 | 30 | +33.3% |
| CN | 50 | 65 | -23.1% |
| DE | 65 | 59 | +10.2% |
| ES | 37 | 30 | +23.3% |
| FR | 52 | 45 | +15.6% |
| GB | 89 | 84 | +6.0% |
| IT | 35 | 34 | +2.9% |
| JP | 39 | 38 | +2.6% |
| MX | 44 | 40 | +10.0% |
| Other developed markets | 182 | 151 | +20.5% |
| Other emerging markets | 212 | 195 | +8.7% |
| Total Geographical Area | 2,357 | 2,296 | +2.7% |
| US | 1,236 | 1,257 | -1.7% |
| Cost of Revenue | 712 | 707 | +0.7% |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | 365 | 336 | +8.6% |
| United States Segment · Operating Segments | 213 | 229 | -7.0% |
| Selling, General & Administrative | 619 | 625 | -1.0% |
| Research And Development Expense Excluding Acquired In Process Cost | 199 | 186 | +7.0% |
| Amortization Of Intangible Assets Not Associated With Single Function | 31 | 34 | -8.8% |
| Restructuring Charges And Acquisition And Divestiture Related Costs | 17 | 2 | +750.0% |
| Interest Expense | 57 | 51 | +11.8% |
| Non-Operating Income (Expense) | -9 | -20 | +55.0% |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | -3 | -2 | -50.0% |
| Income Before Taxes | 761 | 732 | +4.0% |
Show Business Segments breakouts |
|||
| All Other Segments | -159 | -151 | -5.3% |
| International Segment · Operating Segments | 574 | 523 | +9.8% |
| United States Segment · Operating Segments | 830 | 819 | +1.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -342 | -320 | -6.9% |
| Operating Segments | 1,404 | 1,342 | +4.6% |
| Income Tax Expense (Benefit) | 158 | 151 | +4.6% |
| Net Income | 603 | 581 | +3.8% |
Show Equity Components breakouts |
|||
| Retained Earnings | 603 | 581 | +3.8% |
| Net Income | 603 | 581 | +3.8% |
| EPS (Basic) | 1.38 | 1.29 | +7.0% |
| EPS (Diluted) | 1.37 | 1.29 | +6.2% |
| Wtd Avg Shares (Basic) | -1.76 | -1.2 | -46.4% |
| Wtd Avg Shares (Diluted) | -1.77 | -1.25 | -41.0% |
| Gross Profit (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | 756 | 703 | +7.5% |
| United States Segment · Operating Segments | 1,023 | 1,028 | -0.5% |
| Operating Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | 183 | 180 | +1.7% |
| United States Segment · Operating Segments | 193 | 212 | -9.0% |
| Other Non-Operating Income (Expense) | 8 | -1 | +900.0% |
| Comprehensive Income | 587 | 492 | +19.3% |
| Foreign Currency Transaction Gain Loss Before Tax | 10 | 8 | +25.0% |
Balance Sheet
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Accounts Receivable | 1,590 | 1,316 | +20.8% |
| Inventory | 2,430 | 2,306 | +5.4% |
| Other Assets Current | 436 | 377 | +15.6% |
| Total Current Assets | 6,768 | 5,986 | +13.1% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 3,681 | 3,391 | +8.6% |
Show Geography breakouts |
|||
| Non Us | 1,225 | 1,142 | +7.3% |
| US | 2,456 | 2,249 | +9.2% |
| Operating Lease Right-of-Use Assets | 288 | 219 | +31.5% |
| Goodwill | 2,767 | 2,724 | +1.6% |
Show Geography breakouts |
|||
| Non Us | 1,252 | 1,209 | +3.6% |
| US | 1,515 | 1,515 | 0.0% |
| Deferred Tax Assets | 637 | 540 | +18.0% |
| Other Non-Current Assets | 328 | 250 | +31.2% |
| Total Assets | 15,467 | 14,237 | +8.6% |
| Intangible Assets | 784 | 918 | -14.6% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Brands and tradenames | 112 | 121 | -7.4% |
| Developed Technology Rights | 590 | 716 | -17.6% |
| Other Intangible Assets | 82 | 81 | +1.2% |
| Other Assets | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2,312 | 1,987 | +16.4% |
| Intangible Assets Net Excluding Goodwill | 998 | 1,127 | -11.4% |
| Current Liabilities | |||
| Accounts Payable | 487 | 433 | +12.5% |
| Dividends Payable Current | 232 | 224 | +3.6% |
| Accrued Liabilities | 852 | 746 | +14.2% |
| Employee Related Liabilities Current | 410 | 441 | -7.0% |
| Taxes Payable Current | 147 | 93 | +58.1% |
| Other Liabilities Current | 107 | 125 | -14.4% |
| Total Current Liabilities | 2,235 | 3,412 | -34.5% |
| Non-Current Liabilities | |||
| Long-Term Debt | 9,042 | 5,220 | +73.2% |
| Deferred Tax Liabilities | 139 | 167 | -16.8% |
| Operating Lease Liabilities | 196 | 174 | +12.6% |
| Accrued Income Taxes Noncurrent | 276 | 272 | +1.5% |
| Other Non-Current Liabilities | 248 | 222 | +11.7% |
| Total Liabilities | 12,136 | 9,467 | +28.2% |
| Stockholders' Equity | |||
| Common Stock | 5 | 5 | 0.0% |
| Treasury Stock Value | -10,685 | -7,445 | -43.5% |
| Additional Paid-In Capital | 1,101 | 1,182 | -6.9% |
| Retained Earnings | 13,744 | 11,968 | +14.8% |
| Accumulated Other Comprehensive Income | -834 | -940 | +11.3% |
| Total Stockholders' Equity | 3,331 | 4,770 | -30.2% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 3,331 | 4,770 | -30.2% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 2 | — | — |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 70 | 89 | -21.3% |
| Accumulated Other Comprehensive Income | -834 | -940 | +11.3% |
| Accumulated Other Comprehensive Income Loss Derivative Qualifying As Hedge Excluded Component Including Portion Attributable To Noncontrolling Interest | -39 | 62 | -162.9% |
| Accumulated Translation Adjustment | -867 | -1,091 | +20.5% |
| Additional Paid In Capital | 1,101 | 1,182 | -6.9% |
| Common Stock | 5 | 5 | 0.0% |
| Retained Earnings | 13,744 | 11,968 | +14.8% |
| Treasury Stock Common | -10,685 | -7,445 | -43.5% |
| Total Liabilities & Equity | 15,467 | 14,237 | +8.6% |
Cash Flow Statement
| Metric | YTD Q4 2025 | YTD Q4 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 121 | 123 | -1.6% |
Show Business Segments breakouts |
|||
| All Other Segments | 13 | 14 | -7.1% |
| International Segment · Operating Segments | 26 | 23 | +13.0% |
| United States Segment · Operating Segments | 23 | 20 | +15.0% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 26 | 32 | -18.8% |
| Operating Segments | 49 | 43 | +14.0% |
| Stock-Based Compensation | 22 | 19 | +15.8% |
| Asset Impairment Charges | 8 | 15 | -46.7% |
| Inventory Write Down | 16 | 26 | -38.5% |
| Deferred Income Taxes | -48 | -152 | +68.4% |
| Other Non-Cash Items | 1 | -17 | +105.9% |
| Change in Accounts Receivable | -52 | 73 | -171.2% |
| Change in Inventory | 13 | 73 | -82.2% |
| Increase Decrease In Other Operating Assets | 10 | 66 | -84.8% |
| Change in Accounts Payable | 76 | 26 | +192.3% |
| Increase Decrease In Other Operating Liabilities | 88 | 78 | +12.8% |
| Increase Decrease In Accrued Taxes Payable | 35 | -7 | +600.0% |
| Net Cash from Operations | 893 | 905 | -1.3% |
| Investing Activities | |||
| Capital Expenditures | -161 | -216 | +25.5% |
| Payments To Acquire Business Two Net Of Cash Acquired | -14 | 0 | — |
| Payments To Acquire Investments | -1 | -1 | 0.0% |
| Payments For Proceeds From Hedge Investing Activities | 12 | 51 | -76.5% |
| Other Investing Activities | -1 | 0 | — |
| Net Cash from Investing | -166 | 126 | -231.7% |
| Financing Activities | |||
| Share Based Compensation Related Proceeds Net Of Taxes Paid On Withholding Shares | 1 | 2 | -50.0% |
| Share Repurchases | -2,060 | -553 | -272.5% |
| Payments Of Ordinary Dividends | -220 | -194 | -13.4% |
| Net Cash from Financing | -495 | -745 | +33.6% |
| Supplemental | |||
| Income Taxes Paid | 133 | 235 | -43.4% |
| Interest Paid | 36 | 69 | -47.8% |
| Unpaid Capital Expenditures | 1 | -1 | +200.0% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -4 | -13 | +69.2% |
| Net Change in Cash | 228 | 273 | -16.5% |
Values in millions USD. Source: SEC EDGAR 10-K filing.